Schou M, Amdisen A, Jensen S, Olsen T. Occurrence of goiter during lithium treatment. BMJ 1968, 3: 710–3.
Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998, 8: 909–13.
Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemol Ment Health 2006, 2: 23.
Bocchetta A, Bernardi F, Pedditzi M, et al. Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand 1991, 83: 193–8.
Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 1992, 86: 38–41.
Bocchetta A, Cherchi A, Loviselli A, et al. Six-year follow-up of thyroid function during lithium treatment. Acta Psychiatr Scand 1996, 94: 45–8.
Bocchetta A, Mossa P, Velluzzi F, Mariotti S, Del Zompo M, Loviselli A. Ten-year follow-up of thyroid function in lithium patients. J Clin Psychopharmacol 2001, 21: 594–8.
Nemeroff CB, Simon JS, Haggerty JJ Jr, Evans DL. Antithyroid antibodies in depressed patients. Am J Psychiatry 1985, 142: 840–3.
Haggerty JJ Jr, Prange AJ Jr. Borderline hypothyroidism and depression. Annu Rev Med 1995, 46: 37–46.
Kupka RW, Nolen WA, Post RM, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry 2002, 51: 305–11.
Tunbridge WMG, Brewis M, French JM, et al. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) 1981, 282: 258–62.
Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43: 55–68.
Martino E, Loviselli A, Velluzzi F, et al. Endemic goiter and thyroid function in central-southern Sardinia: report on an extensive epidemiological survey. J Endocrinol Invest 1994, 17: 653–7.
Loviselli A, Oppo A, Velluzzi F, et al. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia. J Endocrinol Invest 1999, 22: 660–5.
Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 1999, 175: 336–9.
Kirov G, Tredget J, John R, Owen MJ, Lazarus JH. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. J Affect Disord 2005, 87: 313–7.
Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf) 2001, 55: 501–8.
Martino E, Placidi GF, Sardano G, et al. High incidence of goiter in patients treated with lithium carbonate. Ann Endocrinol (Paris) 1982, 43: 269–76.
Lazarus JH. Is thyroxine during lithium therapy necessary? J Endocrinol Invest 1998, 21: 784–6.
Bartalena L, Bogazzi F, Martino E. Is thyroxine during lithium therapy necessary? J Endocrinol Invest 1999, 22: 220–2.